×
For best experience we recommend to activate Javascript in your browser.
Ferredoxin Reductase antibody (AA 33-219)
This anti-Ferredoxin Reductase antibody is a Rabbit Polyclonal antibody detecting Ferredoxin Reductase in WB, ELISA and IHC. Suitable for Human.
Quick Overview for Ferredoxin Reductase antibody (AA 33-219) (ABIN7569283)
Target
See all Ferredoxin Reductase (FDXR) Antibodies
Ferredoxin Reductase (FDXR)
Reactivity
All reactivities for Ferredoxin Reductase antibodies
Human
Host
All hosts for Ferredoxin Reductase antibodies
Rabbit
Clonality
All clonalities for Ferredoxin Reductase antibodies
Polyclonal
Conjugate
All conjugates for Ferredoxin Reductase antibodies
This Ferredoxin Reductase antibody is un-conjugated
Application
All applications for Ferredoxin Reductase antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-Ferredoxin Reductase Antibody
(hide)
Binding Specificity
All epitopes for Ferredoxin Reductase antibodies
AA 33-219
Purpose
Anti-Human FDXR Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human FDXR (Ser33-Arg219).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for Ferredoxin Reductase
(hide)
Target
Ferredoxin Reductase (FDXR)
Alternative Name
FDXR
Background
ADXR, Adrenodoxin reductase, NADPH:adrenodoxin oxidoreductase, mitochondrial, Ferredoxin reductase, Ferredoxin--NADP(+) reductase, FDXR, AR
UniProt
P22570
Recently viewed
(hide)
Chat with us , powered by LiveChat